Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387563832> ?p ?o ?g. }
- W4387563832 abstract "Strategies to reduce relapse using immunomodulators (IMs) after discontinuing anti-tumor necrosis factor-alpha (TNF-α) antibody treatment are controversial in patients with ulcerative colitis (UC). In this study, we assessed the association between IMs after discontinuing anti-TNF-α antibody treatment and relapse in patients with UC.This retrospective, multicenter cohort study included 257 patients with UC in clinical remission. These patients discontinued anti-TNF-α antibody treatment between June 2010 and March 2019 and were followed up until March 2020. We evaluated the differences in relapse rates between patients with IMs (IM group) and those without IMs (non-IM group) after discontinuing the treatment. Relapse was defined as further undergoing an induction treatment or colectomy. Cox proportional hazards models adjusted for confounders were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for relapse. Exploratory analyses were performed to identify other factors that could predict relapse.During the median follow-up period of 22 months (interquartile range: 10-41), 114 relapses occurred: 42/100 (42.0%) in the IM group and 72/157 (45.9%) in the non-IM group. In the multivariable analysis, IMs were not associated with relapse (HR, 0.95 [95% CI, 0.64-1.41]). In the exploratory analyses, discontinuation due to side effects (HR, 1.83 [95% CI, 1.18-2.82]) and younger age (HR, 0.99 [95% CI, 0.98-1.00]) predicted relapse.Immunomodulators were not associated with relapse after discontinuing anti-TNF-α antibody treatment in patients with UC. Careful patient follow-up is needed when discontinuing due to side effects or when the patient is of a younger age at the time of discontinuation." @default.
- W4387563832 created "2023-10-13" @default.
- W4387563832 creator A5002534181 @default.
- W4387563832 creator A5003915417 @default.
- W4387563832 creator A5003916375 @default.
- W4387563832 creator A5007781775 @default.
- W4387563832 creator A5010212392 @default.
- W4387563832 creator A5013956366 @default.
- W4387563832 creator A5017490136 @default.
- W4387563832 creator A5020747796 @default.
- W4387563832 creator A5021287958 @default.
- W4387563832 creator A5023015196 @default.
- W4387563832 creator A5029088191 @default.
- W4387563832 creator A5041796702 @default.
- W4387563832 creator A5042547276 @default.
- W4387563832 creator A5048721651 @default.
- W4387563832 creator A5053981226 @default.
- W4387563832 creator A5054781859 @default.
- W4387563832 creator A5075958978 @default.
- W4387563832 creator A5086774168 @default.
- W4387563832 date "2023-10-12" @default.
- W4387563832 modified "2023-10-13" @default.
- W4387563832 title "Immunomodulators after the discontinuation of anti‐tumor necrosis factor‐alpha antibody treatment and relapse in ulcerative colitis: A multicenter cohort study" @default.
- W4387563832 cites W1441706726 @default.
- W4387563832 cites W1500017547 @default.
- W4387563832 cites W1545237033 @default.
- W4387563832 cites W1907039258 @default.
- W4387563832 cites W1984705525 @default.
- W4387563832 cites W1985910822 @default.
- W4387563832 cites W1995529175 @default.
- W4387563832 cites W2009028255 @default.
- W4387563832 cites W2029044316 @default.
- W4387563832 cites W2032473143 @default.
- W4387563832 cites W2054009293 @default.
- W4387563832 cites W2056873984 @default.
- W4387563832 cites W2068451449 @default.
- W4387563832 cites W2080450248 @default.
- W4387563832 cites W2092863985 @default.
- W4387563832 cites W2119335895 @default.
- W4387563832 cites W2124433195 @default.
- W4387563832 cites W2127482800 @default.
- W4387563832 cites W2146101488 @default.
- W4387563832 cites W2171297959 @default.
- W4387563832 cites W2171789845 @default.
- W4387563832 cites W2188248802 @default.
- W4387563832 cites W2284889751 @default.
- W4387563832 cites W2321205867 @default.
- W4387563832 cites W2322130077 @default.
- W4387563832 cites W2431059385 @default.
- W4387563832 cites W2547301230 @default.
- W4387563832 cites W2562136274 @default.
- W4387563832 cites W2740303420 @default.
- W4387563832 cites W2758903736 @default.
- W4387563832 cites W2809534736 @default.
- W4387563832 cites W2810508066 @default.
- W4387563832 cites W2908027233 @default.
- W4387563832 cites W3115410759 @default.
- W4387563832 cites W3156907277 @default.
- W4387563832 cites W3157710720 @default.
- W4387563832 cites W4205389315 @default.
- W4387563832 cites W4211050664 @default.
- W4387563832 doi "https://doi.org/10.1111/jgh.16376" @default.
- W4387563832 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37823425" @default.
- W4387563832 hasPublicationYear "2023" @default.
- W4387563832 type Work @default.
- W4387563832 citedByCount "0" @default.
- W4387563832 crossrefType "journal-article" @default.
- W4387563832 hasAuthorship W4387563832A5002534181 @default.
- W4387563832 hasAuthorship W4387563832A5003915417 @default.
- W4387563832 hasAuthorship W4387563832A5003916375 @default.
- W4387563832 hasAuthorship W4387563832A5007781775 @default.
- W4387563832 hasAuthorship W4387563832A5010212392 @default.
- W4387563832 hasAuthorship W4387563832A5013956366 @default.
- W4387563832 hasAuthorship W4387563832A5017490136 @default.
- W4387563832 hasAuthorship W4387563832A5020747796 @default.
- W4387563832 hasAuthorship W4387563832A5021287958 @default.
- W4387563832 hasAuthorship W4387563832A5023015196 @default.
- W4387563832 hasAuthorship W4387563832A5029088191 @default.
- W4387563832 hasAuthorship W4387563832A5041796702 @default.
- W4387563832 hasAuthorship W4387563832A5042547276 @default.
- W4387563832 hasAuthorship W4387563832A5048721651 @default.
- W4387563832 hasAuthorship W4387563832A5053981226 @default.
- W4387563832 hasAuthorship W4387563832A5054781859 @default.
- W4387563832 hasAuthorship W4387563832A5075958978 @default.
- W4387563832 hasAuthorship W4387563832A5086774168 @default.
- W4387563832 hasBestOaLocation W43875638321 @default.
- W4387563832 hasConcept C119060515 @default.
- W4387563832 hasConcept C126322002 @default.
- W4387563832 hasConcept C141071460 @default.
- W4387563832 hasConcept C207103383 @default.
- W4387563832 hasConcept C2776667177 @default.
- W4387563832 hasConcept C2778715236 @default.
- W4387563832 hasConcept C2779134260 @default.
- W4387563832 hasConcept C2780479503 @default.
- W4387563832 hasConcept C44249647 @default.
- W4387563832 hasConcept C50382708 @default.
- W4387563832 hasConcept C71924100 @default.
- W4387563832 hasConcept C72563966 @default.
- W4387563832 hasConcept C90924648 @default.
- W4387563832 hasConceptScore W4387563832C119060515 @default.